Venous thromboEmbolism Risk Profiles in Chinese hoSpitalized patiEnts (VERSE Study)
Venous Thromboembolism Risk Profiles Among Hospitalized Patients in Chinese General Hospital- a Cross-sectional Single-institution Based Study
研究概览
地位
条件
详细说明
In this study, the investigators recruited adult inpatients attending Tsinghua Chang Gung Hospital in Beijing from June 2018 to April 2020, screened for patients with a hospital stay over 3 days and new-onset of VTE during hospital stay, and identified the in-hospital VTE patients after excluding patients who presented for DVT and/or PE. Similarly, negative patients were selected by not having a VTE during hospital stay. The diagnosis of VTE was confirmed as the occurrence of a critical value alert during hospitalization, which was predefined as ultrasound/radiology report of DVT or/and PE. Data was collected from the TEACH database of Beijing Tsinghua Chang Gung Hospital affiliated with Tsinghua University.
Patients baseline characteristics were extracted from database. VTE risk assessment was conducted with either Caprini risk assessment model (surgical patients) or Padua prediction score (medical patients). The evaluation was started upon admission and regularly repeated depending on the patient's condition. The last evaluation was conducted before discharge. The D-dimer values during hospitalization were also collected.
The rate of in-hospital VTE, distributions of in-hospital VTE patients and the receiver operating characteristic curves were analyzed.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Beijing、中国、102218
- Beijing Tsinghua Chang Gung Hosipital
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Age 18 and over, male or female
- Inpatients with a hospital stay over 3 days
- With or without new-onset of VTE during their stay
Exclusion Criteria:
- Patients who presented for DVT and/or PE
- Patients who were admitted in emergency department
学习计划
研究是如何设计的？
设计细节
队列和干预
团体/队列 |
|---|
|
In-hospital VTE group
In-hospital VTE group includes patients who were with a hospital stay over 3 days and new-onset of VTE during their stay.
Patients who presented for VTE were excluded.
|
|
Negative group
Negative group includes patients who were with a hospital stay over 3 days and did not have a VTE during their hospital stay.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
The rate of in-hospital VTE
大体时间：From June 2018 to April 2020
|
The diagnosis of VTE was confirmed as the occurrence of a critical value alert during hospitalization, which was predefined as ultrasound/radiology report of DVT or/and PE.
|
From June 2018 to April 2020
|
|
Caprini risk assessment model scores
大体时间：Through discharge, an average of 20 days
|
Patients were stratified of VTE risk as very low risk (0), low risk (1-2), medium risk (3-4), high risk (5 and over).
|
Through discharge, an average of 20 days
|
|
Padua prediction score scores
大体时间：Through discharge, an average of 20 days
|
Patients were stratified of VTE risk as low risk (0-3) and high risk (4 and over).
|
Through discharge, an average of 20 days
|
|
D-dimer values
大体时间：Through discharge, an average of 20 days
|
The upper normal value 0.55mg/L FEU was used.
|
Through discharge, an average of 20 days
|
合作者和调查者
调查人员
- 首席研究员：Weiwei Wu, MD、Beijing Tsinghua Chang Gung Hospital
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 19242-4-01
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.